Fluvoxamine Maleate Capsule, Extended Release
Product Images NDC 0228-2849

7 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Fluvoxamine Maleate (NDC 0228-2849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ebfb06fd-figure-01 (Image 1)

Ebfb06fd-figure-01 (Image 1)
Packaging label for Fluvoxamine Maleate extended release capsules, showing strengths of 100 mg and 150 mg. The label highlights the drug is for further processing and is provided by Actavis Pharma, Inc. The design includes capsules and numeric strength indicators on a blue and white background.*
FDA Label Image

Ebfb06fd-figure-02 (Image 2)

Ebfb06fd-figure-02 (Image 2)
Packaging label for Fluvoxamine Maleate extended release capsules in 100 mg strength. The image shows an amber bottle with a white child-resistant cap and a label indicating the product name, strength, dosage form, and a note that it is manufactured by Actavis Pharma, Inc. The label includes a barcode and markings consistent with pharmaceutical packaging.*
FDA Label Image

Ebfb06fd-figure-03 (Image 3)

Ebfb06fd-figure-03 (Image 3)
Chemical structure diagram showing the molecular structures of compounds related to Fluvoxamine Maleate, including specific functional groups such as trifluoromethyl and ester groups. The image depicts chemical bonds and atomic arrangements characteristic of this active ingredient.*
FDA Label Image

Ebfb06fd-figure-04 (Image 4)

Ebfb06fd-figure-04 (Image 4)
Extended release capsules of Fluvoxamine Maleate in 100 mg and 150 mg strengths, packaged by Actavis Pharma, Inc. The image shows two separate white capsules with printed dosage markings in black on each, corresponding to the strength indicated.*
FDA Label Image

Ebfb06fd-figure-05 (Image 5)

Ebfb06fd-figure-05 (Image 5)
Fluvoxamine Maleate extended-release capsule label for 100 mg strength. The label includes the drug name, strength, dosage form, and is produced by Actavis Pharma, Inc. The image shows the capsule with a clear imprint displaying the strength and other identifying codes.*
FDA Label Image

1 (Image 6)

1 (Image 6)
Label for Fluvoxamine Maleate extended-release capsules, 100 mg strength, in a 30-capsule bottle. The label includes dosing instructions, storage conditions, and manufacturer details for Actavis Pharma, Inc., with directions to dispense the Medication Guide. It also notes this is for prescription use only.*
FDA Label Image

1 (Image 7)

1 (Image 7)
Label for Fluvoxamine Maleate 150 mg extended-release capsules by Actavis Pharma, Inc. The label indicates a 30-capsule prescription package for once-a-day use with dispensing instructions, storage conditions, and a barcode. The labeler is Actavis Elizabeth LLC, Elizabeth, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.